You have 9 free searches left this month | for more free features.

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer Trial in Baltimore (procedure, drug, other)

Recruiting
  • Stage III Ovarian Cancer
  • +6 more
  • Cytoreductive Surgery (CRS)
  • +6 more
  • Baltimore, Maryland
    Mercy Medical Center
Aug 30, 2022

An Audit of Cytoreductive Surgery and Hyperthermic

Recruiting
  • Colorectal Cancer
  • +2 more
  • Hyperthermic intraperitoneal chemotherapy
  • Mumbai, Maharashtra, India
    Tata Memorial Hospital
Apr 25, 2022

Appendix Cancer, Colorectal Cancer Trial in United States (Cytoreductive Surgery, HIPEC with Mitomycin-C, EPIC with FUDR and

Recruiting
  • Appendix Cancer
  • Colorectal Cancer
  • Cytoreductive Surgery
  • +2 more
  • Miami, Florida
  • +8 more
Jan 12, 2023

Cytoreductive Surgery, Hyperthermic Intraperitoneal Chemo, Hydration Trial in Beijing (Urine-guided hydration, Routine

Not yet recruiting
  • Cytoreductive Surgery
  • +5 more
  • Urine-guided hydration
  • +3 more
  • Beijing, China
    Aerospace Center Hospital
Jul 11, 2023

Peritoneal Cancer Trial in Houston (Local Anesthetic Solution, Bupivacaine HCl, Liposomal Bupivacaine)

Completed
  • Peritoneal Cancer
  • Local Anesthetic Solution
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 27, 2022

Colorectal Tumors, Colorectal Cancer, Colorectal Cancer Metastatic Trial in Guangzhou (Preoperative systematic therapy,

Not yet recruiting
  • Colorectal Neoplasms
  • +8 more
  • Preoperative systematic therapy
  • +2 more
  • Guangzhou, Guangdong, China
    Sixth Affiliated Hospital of Sun Yat-sen University
Apr 28, 2022

Ileus Trial in La Jolla (Alvimopan, Placebo)

Terminated
  • Ileus
  • La Jolla, California
    UCSD Moores Cancer Center
Jul 19, 2021

ERAS® Guidelines Validation of CRS With or Without HIPEC

Recruiting
  • Peritoneal Diseases
  • Pre-ERAS® phase (current clinical practice)
  • Post-ERAS® implementation phase
  • Dallas, Texas
  • +2 more
Dec 22, 2021

Peritoneal Metastases From Colorectal Cancer Trial in Milano (Patient-tailored hyperthermic intraperitoneal chemo (HIPEC))

Recruiting
  • Peritoneal Metastases From Colorectal Cancer
  • Patient-tailored hyperthermic intraperitoneal chemotherapy (HIPEC)
  • Milano, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Sep 26, 2023

Severe Neutropenia After HIPEC Using Mitomycin-C

Recruiting
  • Colorectal Cancer Metastatic
  • +3 more
  • Intraoperative blood and peritoneal fluid samplings during HIPEC
  • Seoul, Korea, Republic of
    Division of Colon and Rectal Surgery, Department of Surgery, Gan
Aug 21, 2022

Gastric Cancer With Peritoneal Metastasis (PCI<12) Trial in Seoul (CRS+HIPEC)

Recruiting
  • Gastric Cancer With Peritoneal Metastasis (PCI<12)
  • Seoul, Korea, Republic of
    Department of Surgery, Yonsei University College of Medicine
Apr 21, 2022

Ovarian Cancer Trial (Cytoreductive Surgery (CRS), Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Neoadjuvant Chemotherapy

Completed
  • Ovarian Cancer
  • Cytoreductive Surgery (CRS)
  • +4 more
  • (no location specified)
Mar 17, 2021

Ovarian Cancer Trial in Houston (Cytoreductive surgery)

Recruiting
  • Ovarian Cancer
  • Cytoreductive surgery
  • Houston, Texas
    MD Anderson Cancer Center
Jul 28, 2022

Cytoreductive Surgery, Hyperthermic Intra-peritoneal Chemo, Peritoneal Cancer Trial in Seoul (Arm I (QL block and multimodal

Recruiting
  • Cytoreductive Surgery
  • +2 more
  • Arm I (QL block and multimodal analgesia), Arm II (multimodal analgesia without regional block)
  • Seoul, Korea, Republic of
    Gangnam Severance Hospital
Dec 2, 2022

Ovarian Cancer, Fallopian Tubes Cancer, Peritoneal Cancer Trial in United States (Secondary Cytoreductive Surgery, Carboplatin

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • Secondary Cytoreductive Surgery
  • +2 more
  • Hartford, Connecticut
  • +10 more
Feb 23, 2022

Hyperthermic Intraperitoneal Trial in Houston (Allon System)

Not yet recruiting
  • Hyperthermic Intraperitoneal
  • Allon System
  • Houston, Texas
    MD Anderson Cancer Center
Jul 25, 2022

Colorectal Cancer Trial (anesthetic method)

Withdrawn
  • Colorectal Cancer
  • anesthetic method
  • (no location specified)
Jul 11, 2023

Ovarian Cancer Trial in Worldwide (cisplatin)

Recruiting
  • Ovarian Cancer
  • New York, New York
  • +20 more
Oct 17, 2022

Ovarian Cancer, Ovary Tumor, Ovarian Tumors Trial in Wuhan (HIPEC, CRS, IVCT)

Active, not recruiting
  • Ovarian Cancer
  • +5 more
  • HIPEC
  • +2 more
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
May 28, 2020

Stomach Tumor, Peritoneal Carcinomatosis Trial in Amsterdam (Cytoreductive surgery + Gastrecomy, Hyperthermic Intraperitoneal

Recruiting
  • Stomach Neoplasm
  • Peritoneal Carcinomatosis
  • Cytoreductive surgery + Gastrecomy
  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
  • Amsterdam, Netherlands
    Antoni van Leeuwenhoek/ Netherlands Cancer institute
Feb 14, 2022

Ovarian Cancer, Intraperitoneal Chemo Trial in Montpellier (Intraperitoneal chemo during surgery)

Recruiting
  • Ovarian Cancer
  • Intraperitoneal Chemotherapy
  • Intraperitoneal chemotherapy during surgery
  • Montpellier, France
    Institut du Cancer de Montpellier - Val d'Aurelle
Mar 11, 2022

Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial (Cisplatin, No treatment)

Not yet recruiting
  • Stage III Ovarian Cancer
  • +5 more
  • (no location specified)
Dec 12, 2022

Major Postoperative Complications AfterSurgery of Resection With

Completed
  • Peritoneal Carcinomatosis
  • Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
  • Reims, France
    Chu Reims
Oct 19, 2022

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +32 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Peritoneal Carcinomatosis Trial in Lexington (Mitomycin C, flat dose 40 mg, Mitomycin C, weight-based dose 12.5 mg/m2)

Recruiting
  • Peritoneal Carcinomatosis
  • Mitomycin C, flat dose 40 mg
  • Mitomycin C, weight-based dose 12.5 mg/m2
  • Lexington, Kentucky
    University of Kentucky
Mar 1, 2022